Search

Taylor V. Oh

Examiner (ID: 2006, Phone: (571)272-0689 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1621, 1623, 1625, 1622, 1711
Total Applications
2700
Issued Applications
1922
Pending Applications
233
Abandoned Applications
559

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18228482 [patent_doc_number] => 20230067476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/520857 [patent_app_country] => US [patent_app_date] => 2021-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 174161 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 954 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520857 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/520857
3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Nov 7, 2021 Issued
Array ( [id] => 20633416 [patent_doc_number] => 12594279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-04-07 [patent_title] => Composition for preventing or treating TNF-a-related disease, comprising hydroflumethiazide as active ingredient [patent_app_type] => utility [patent_app_number] => 18/035627 [patent_app_country] => US [patent_app_date] => 2021-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 2757 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035627 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/035627
Composition for preventing or treating TNF-a-related disease, comprising hydroflumethiazide as active ingredient Nov 4, 2021 Issued
Array ( [id] => 20142780 [patent_doc_number] => 12377095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-05 [patent_title] => Use of ligustrazine nitrone derivatives in treatment and prevention of diabetic complication diseases [patent_app_type] => utility [patent_app_number] => 17/300777 [patent_app_country] => US [patent_app_date] => 2021-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 23 [patent_no_of_words] => 6369 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300777 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/300777
Use of ligustrazine nitrone derivatives in treatment and prevention of diabetic complication diseases Nov 2, 2021 Issued
Array ( [id] => 18877381 [patent_doc_number] => 20240000750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => METHOD FOR PREPARING CRYSTALLINE PARTICLES OF 1-(3-CYANO-1-ISOPROPYL-INDOLE-5-YL)PYRAZOLE-4-CARBOXYLIC ACID, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 18/251646 [patent_app_country] => US [patent_app_date] => 2021-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6720 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251646 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251646
METHOD FOR PREPARING CRYSTALLINE PARTICLES OF 1-(3-CYANO-1-ISOPROPYL-INDOLE-5-YL)PYRAZOLE-4-CARBOXYLIC ACID, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Nov 1, 2021 Pending
Array ( [id] => 17520443 [patent_doc_number] => 20220106292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => SMALL MOLECULE INHIBITORS OF SHARED EPITOPE-CALRETICULIN INTERACTIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/501572 [patent_app_country] => US [patent_app_date] => 2021-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11007 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501572 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/501572
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use Oct 13, 2021 Issued
Array ( [id] => 17385480 [patent_doc_number] => 20220033332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => Chromium-Catalyzed Production of Alcohols From Hydrocarbons [patent_app_type] => utility [patent_app_number] => 17/501020 [patent_app_country] => US [patent_app_date] => 2021-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23766 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501020 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/501020
Chromium-catalyzed production of alcohols from hydrocarbons Oct 13, 2021 Issued
Array ( [id] => 19060106 [patent_doc_number] => 11939314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-26 [patent_title] => Quinolin-2-one derivatives [patent_app_type] => utility [patent_app_number] => 17/499278 [patent_app_country] => US [patent_app_date] => 2021-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39274 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 331 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499278 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/499278
Quinolin-2-one derivatives Oct 11, 2021 Issued
Array ( [id] => 18861780 [patent_doc_number] => 20230416215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => OXIDATIVE PRETREATMENT OF CARBOHYDRATE DEHYDRATION PRODUCTS COMPRISING HUMINS [patent_app_type] => utility [patent_app_number] => 18/248846 [patent_app_country] => US [patent_app_date] => 2021-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13087 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248846 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/248846
OXIDATIVE PRETREATMENT OF CARBOHYDRATE DEHYDRATION PRODUCTS COMPRISING HUMINS Oct 10, 2021 Pending
Array ( [id] => 18176910 [patent_doc_number] => 20230037639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => 3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/493055 [patent_app_country] => US [patent_app_date] => 2021-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 106350 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 813 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493055 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/493055
3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Oct 3, 2021 Issued
Array ( [id] => 18895141 [patent_doc_number] => 20240010626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => METHOD FOR PRODUCING CARBONYLAMINOFURANS [patent_app_type] => utility [patent_app_number] => 18/247795 [patent_app_country] => US [patent_app_date] => 2021-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2166 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247795 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/247795
METHOD FOR PRODUCING CARBONYLAMINOFURANS Oct 3, 2021 Abandoned
Array ( [id] => 17343567 [patent_doc_number] => 20220009898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => METHOD FOR PRODUCING HETEROCYCLIDENE ACETAMIDE DERIVATIVE [patent_app_type] => utility [patent_app_number] => 17/486265 [patent_app_country] => US [patent_app_date] => 2021-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17486265 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/486265
Method for producing heterocyclidene acetamide derivative Sep 26, 2021 Issued
Array ( [id] => 18770758 [patent_doc_number] => 20230365542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => Selective Agonists of 5-HT2A Receptor and Methods of Use [patent_app_type] => utility [patent_app_number] => 18/247057 [patent_app_country] => US [patent_app_date] => 2021-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38460 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247057 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/247057
Selective Agonists of 5-HT2A Receptor and Methods of Use Sep 26, 2021 Pending
Array ( [id] => 17335926 [patent_doc_number] => 20220002257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => PRODUCTION METHOD FOR HEMIAMINAL COMPOUND AND PRODUCTION METHOD FOR HETEROCYCLIC COMPOUND [patent_app_type] => utility [patent_app_number] => 17/480822 [patent_app_country] => US [patent_app_date] => 2021-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6748 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480822 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/480822
Production method for hemiaminal compound and production method for heterocyclic compound Sep 20, 2021 Issued
Array ( [id] => 18752375 [patent_doc_number] => 20230355607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-09 [patent_title] => NEW MEDICAL USE OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) MODULATORS [patent_app_type] => utility [patent_app_number] => 18/025979 [patent_app_country] => US [patent_app_date] => 2021-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025979 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025979
NEW MEDICAL USE OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) MODULATORS Sep 16, 2021 Pending
Array ( [id] => 18808545 [patent_doc_number] => 20230382879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => Production process of alkylene oxides from alkylene carbonates [patent_app_type] => utility [patent_app_number] => 18/245909 [patent_app_country] => US [patent_app_date] => 2021-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3467 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18245909 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/245909
Production process of alkylene oxides from alkylene carbonates Sep 12, 2021 Abandoned
Array ( [id] => 18603380 [patent_doc_number] => 11744820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-05 [patent_title] => Inhibitors of microbially induced amyloid [patent_app_type] => utility [patent_app_number] => 17/447178 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 67 [patent_no_of_words] => 38312 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17447178 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/447178
Inhibitors of microbially induced amyloid Sep 7, 2021 Issued
Array ( [id] => 17953477 [patent_doc_number] => 11479568 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-25 [patent_title] => Silacrown ethers, pharmaceutical compositions thereof, and therapeutic applications thereof [patent_app_type] => utility [patent_app_number] => 17/464301 [patent_app_country] => US [patent_app_date] => 2021-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4478 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464301 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/464301
Silacrown ethers, pharmaceutical compositions thereof, and therapeutic applications thereof Aug 31, 2021 Issued
Array ( [id] => 18793881 [patent_doc_number] => 11827633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-28 [patent_title] => Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders [patent_app_type] => utility [patent_app_number] => 17/409513 [patent_app_country] => US [patent_app_date] => 2021-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43795 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 648 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409513 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/409513
Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders Aug 22, 2021 Issued
Array ( [id] => 18700016 [patent_doc_number] => 11786502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => Method of treatment [patent_app_type] => utility [patent_app_number] => 17/407921 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1311 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17407921 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/407921
Method of treatment Aug 19, 2021 Issued
Array ( [id] => 17274357 [patent_doc_number] => 20210380555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => PROCESS FOR PREPARING 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)NICOTINAMIDE [patent_app_type] => utility [patent_app_number] => 17/407340 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3316 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17407340 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/407340
Process for preparing 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide Aug 19, 2021 Issued
Menu